Hochschulschrift
The Role of DREAM/MMB-mediated mitotic gene expression downstream of mutated K-Ras in lung cancer
- Weitere Titel
-
Die Rolle DREAM/MMB-vermittelter mitotischer Genexpression unterhalb von mutiertem K-Ras in Lungenkrebs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Würzburg, Universität Würzburg, Dissertation, 2017
- Schlagwort
-
Nicht-kleinzelliges Bronchialkarzinom (NSCLC)
Lungenkrebs
Mitose
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2017
- Urheber
- Beteiligte Personen und Organisationen
-
Gaubatz, Stefan
Paeschke, Katrin
Murphy, Daniel J.
- URN
-
urn:nbn:de:bvb:20-opus-154108
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Iltzsche, Fabian
- Gaubatz, Stefan
- Paeschke, Katrin
- Murphy, Daniel J.
- Universität Würzburg
Entstanden
- 2017
Ähnliche Objekte (12)
The Role of DREAM/MMB-mediated mitotic gene expression downstream of mutated K-Ras in lung cancer : = Die Rolle DREAM/MMB-vermittelter mitotischer Genexpression unterhalb von mutiertem K-Ras in Lungenkrebs
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines
Kras
"KRAS
Lasting response by vertical inhibition with cetuximab and trametinib in \(\it KRAS\)-mutated colorectal cancer patient-derived xenografts
DV-47/19.- Ersatzteilkatalog für die Kraftfahrzeuge KRAS-214, KRAS-219, KRAS-221 und KRAS-222
Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer
Klau - Kras
The Role of DREAM/MMB-mediated mitotic gene expression downstream of mutated K-Ras in lung cancer : = Die Rolle DREAM/MMB-vermittelter mitotischer Genexpression unterhalb von mutiertem K-Ras in Lungenkrebs
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines
Kras
"KRAS
Lasting response by vertical inhibition with cetuximab and trametinib in \(\it KRAS\)-mutated colorectal cancer patient-derived xenografts
DV-47/19.- Ersatzteilkatalog für die Kraftfahrzeuge KRAS-214, KRAS-219, KRAS-221 und KRAS-222
Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer
Klau - Kras
The Role of DREAM/MMB-mediated mitotic gene expression downstream of mutated K-Ras in lung cancer : = Die Rolle DREAM/MMB-vermittelter mitotischer Genexpression unterhalb von mutiertem K-Ras in Lungenkrebs
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines
Kras
"KRAS
Lasting response by vertical inhibition with cetuximab and trametinib in \(\it KRAS\)-mutated colorectal cancer patient-derived xenografts
DV-47/19.- Ersatzteilkatalog für die Kraftfahrzeuge KRAS-214, KRAS-219, KRAS-221 und KRAS-222
Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer